ReP USP - Resultado da busca

Artigo de periodico
Recent advances in mitigating biofilms on medical devices (2024)
Lirio, Adriana Cogo Malgueiro ; Ghisleni, Daniela Dal Molim ; Chellappan, Dinesh Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli
Source: ISAR Journal of Medical and Pharmaceutical Science. Unidade: FCF
Subjects: BIOFILMES, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRIO, Adriana Cogo Malgueiro et al. Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, v. 2, p. 19-22, 2024Tradução . . Disponível em: https://dx.doi.org/10.5281/zenodo.10876918. Acesso em: 06 nov. 2024.
APA
Lirio, A. C. M., Ghisleni, D. D. M., Chellappan, D. K., Dua, K., & Pinto, T. de J. A. (2024). Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, 2, 19-22. doi:10.5281/zenodo.10876918
NLM
Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918
Vancouver
Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918
Artigo de periodico
Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments (2023)
Lirio, Adriana Cogo Malgueiro ; Diaz, Victor A. Febo; Chellappan, Dinesh Kumar ; Dua, Kamal ; Lourenço, Felipe Rebello ; Pinto, Terezinha de Jesus Andreoli
Source: Journal of Pharmaceutical Innovation. Unidade: FCF
Subjects: FÁRMACOS, MONITORAMENTO AMBIENTAL, CONTROLE DE PROCESSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRIO, Adriana Cogo Malgueiro et al. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, v. 18, p. 1362-1370, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12247-023-09719-4. Acesso em: 06 nov. 2024.
APA
Lirio, A. C. M., Diaz, V. A. F., Chellappan, D. K., Dua, K., Lourenço, F. R., & Pinto, T. de J. A. (2023). Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, 18, 1362-1370. doi:10.1007/s12247-023-09719-4
NLM
Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s12247-023-09719-4
Vancouver
Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s12247-023-09719-4
Artigo de periodico
Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells (2023)
Rubis, Gabriele De; Paudel, Keshav Raj ; Liu, Gang ; Agarwal, Vishwesh ; MacLoughlin, Ronan ; Pinto, Terezinha de Jesus Andreoli ; Singh, Sachin Kumar ; Adams, Jon ; Nammi, Srinivas ; Chellappan, Dinesh Kumar ; Oliver, Brian Gregory George ; Hansbro, Philip Michael; Dua, Kamal
Source: Toxicology in Vitro. Unidade: FCF
Subjects: NANOPARTÍCULAS, CÉLULAS EPITELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUBIS, Gabriele De et al. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells. Toxicology in Vitro, v. 92, p. 1-9 art. 105660, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.tiv.2023.105660. Acesso em: 06 nov. 2024.
APA
Rubis, G. D., Paudel, K. R., Liu, G., Agarwal, V., MacLoughlin, R., Pinto, T. de J. A., et al. (2023). Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells. Toxicology in Vitro, 92, 1-9 art. 105660. doi:10.1016/j.tiv.2023.105660
NLM
Rubis GD, Paudel KR, Liu G, Agarwal V, MacLoughlin R, Pinto T de JA, Singh SK, Adams J, Nammi S, Chellappan DK, Oliver BGG, Hansbro PM, Dua K. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells [Internet]. Toxicology in Vitro. 2023 ; 92 1-9 art. 105660.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.1016/j.tiv.2023.105660
Vancouver
Rubis GD, Paudel KR, Liu G, Agarwal V, MacLoughlin R, Pinto T de JA, Singh SK, Adams J, Nammi S, Chellappan DK, Oliver BGG, Hansbro PM, Dua K. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells [Internet]. Toxicology in Vitro. 2023 ; 92 1-9 art. 105660.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.1016/j.tiv.2023.105660
Artigo de periodico
Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems (2022)
Prasher, Parteek ; Sharma, Mousmee ; Singh, Sachin Kumar ; Gulati, Monica ; Jha, Niraj Kumar ; Gupta, Piyush Kumar ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Zacconi, Flavia ; Pinto, Terezinha de Jesus Andreoli ; Chan, Yinghan ; Liu, Gang; Paudel, Keshav Raj ; Hansbro, Philip Michael ; Oliver, Brian Gregory George; Dua, Kamal
Source: Chemico Biological Interactions. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, MUCO, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, v. 365, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2022.110048. Acesso em: 06 nov. 2024.
APA
Prasher, P., Sharma, M., Singh, S. K., Gulati, M., Jha, N. K., Gupta, P. K., et al. (2022). Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, 365, 1-14. doi:10.1016/j.cbi.2022.110048
NLM
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Vancouver
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Artigo de periodico
Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review (2021)
Prasher, Parteek ; Sharma, Mousmee ; Zacconi, Flavia ; Gupt, Gaurav ; Aljabali, Alaa A ; Mishra, Vijay ; Tambuwala, Murtaza M ; Kapoor, Deepak N ; Negi, Poonam ; Pinto, Terezinha de Jesus Andreoli ; Singh, Inderbir ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Current Organic Chemistry. Unidade: FCF
Subjects: QUIMIOTERÁPICOS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, v. 25, p. 654-668, 2021Tradução . . Disponível em: https://doi.org/10.2174/1385272824999200820152501. Acesso em: 06 nov. 2024.
APA
Prasher, P., Sharma, M., Zacconi, F., Gupt, G., Aljabali, A. A., Mishra, V., et al. (2021). Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, 25, 654-668. doi:10.2174/1385272824999200820152501
NLM
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1385272824999200820152501
Vancouver
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1385272824999200820152501
Artigo de periodico
Advanced drug delivery systems targeting NF-κB in respiratory diseases (2021)
Prasher, Parteek ; Sharma, Mousmee ; Chellappan, Dinesh Kumar ; Gupta, Gaurav ; Jha, Niraj Kumar; Singh, Sachin Kumar; MacLoughlin, Ronan ; Pinto, Terezinha de Jesus Andreoli ; Löbenberg, Raimar ; Dua, Kamal
Source: Future Medicinal Chemistry. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, v. 13, n. 13, p. 1087-1090, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0013. Acesso em: 06 nov. 2024.
APA
Prasher, P., Sharma, M., Chellappan, D. K., Gupta, G., Jha, N. K., Singh, S. K., et al. (2021). Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, 13( 13), 1087-1090. doi:10.4155/fmc-2021-0013
NLM
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 nov. 06 ] Available from: https://doi.org/10.4155/fmc-2021-0013
Vancouver
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 nov. 06 ] Available from: https://doi.org/10.4155/fmc-2021-0013
Artigo de periodico
Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases (2021)
Chan, Yinghan ; MacLoughlin, Ronan ; Tambuwala, Murtaza M ; Pabari, Ritesh M ; Singh, Sachin Kumar ; Pinto, Terezinha de Jesus Andreoli ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, NANOTECNOLOGIA, INFLAMAÇÃO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAN, Yinghan et al. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, v. 16, n. 16, p. 1351–1355, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0087. Acesso em: 06 nov. 2024.
APA
Chan, Y., MacLoughlin, R., Tambuwala, M. M., Pabari, R. M., Singh, S. K., Pinto, T. de J. A., et al. (2021). Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, 16( 16), 1351–1355. doi:10.2217/nnm-2021-0087
NLM
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2217/nnm-2021-0087
Vancouver
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2217/nnm-2021-0087
Parte de monografia/livro
Pulmonary biodhesive drug delivery systems and their applications (2020)
Wadhwa, Ridhima; Chellappan, Dinesh Kumar; Maurya, Pawan Kumar; Pinto, Terezinha de Jesus Andreoli ; Collet, Trudi; Dureja, Harish; Hansbro, Philip M; Dua, Kamal; Bharathala, Subhashini; Aggarwal, Taru; Sehgal, Nikita; Kumar, Nitesh; Gupta, Gaurav
Source: Bioadhesives in drug delivery. Unidade: FCF
Subjects: FÁRMACOS (SISTEMA RESPIRATÓRIO), DOENÇAS RESPIRATÓRIAS, NANOPARTÍCULAS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WADHWA, Ridhima et al. Pulmonary biodhesive drug delivery systems and their applications. Bioadhesives in drug delivery. Tradução . Hoboken: Wiley-Scrivener, 2020. . . Acesso em: 06 nov. 2024.
APA
Wadhwa, R., Chellappan, D. K., Maurya, P. K., Pinto, T. de J. A., Collet, T., Dureja, H., et al. (2020). Pulmonary biodhesive drug delivery systems and their applications. In Bioadhesives in drug delivery. Hoboken: Wiley-Scrivener.
NLM
Wadhwa R, Chellappan DK, Maurya PK, Pinto T de JA, Collet T, Dureja H, Hansbro PM, Dua K, Bharathala S, Aggarwal T, Sehgal N, Kumar N, Gupta G. Pulmonary biodhesive drug delivery systems and their applications. In: Bioadhesives in drug delivery. Hoboken: Wiley-Scrivener; 2020. [citado 2024 nov. 06 ]
Vancouver
Wadhwa R, Chellappan DK, Maurya PK, Pinto T de JA, Collet T, Dureja H, Hansbro PM, Dua K, Bharathala S, Aggarwal T, Sehgal N, Kumar N, Gupta G. Pulmonary biodhesive drug delivery systems and their applications. In: Bioadhesives in drug delivery. Hoboken: Wiley-Scrivener; 2020. [citado 2024 nov. 06 ]
Artigo de periodico
Nanocarriers: more than tour de force for thymoquinone (2020)
Rathore, Charul; Rathbone, Michael J; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M ; Pinto, Terezinha de Jesus Andreoli ; Dureja, Harish; Hemrajani, Chetna; Gupta, Gaurav ; Dua, Kamal; Negi, Poonam
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: NANOPARTÍCULAS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATHORE, Charul et al. Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, v. 17, n. 4, p. 479-494, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1730808. Acesso em: 06 nov. 2024.
APA
Rathore, C., Rathbone, M. J., Chellappan, D. K., Tambuwala, M. M., Pinto, T. de J. A., Dureja, H., et al. (2020). Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, 17( 4), 479-494. doi:10.1080/17425247.2020.1730808
NLM
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1080/17425247.2020.1730808
Vancouver
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1080/17425247.2020.1730808
Parte de monografia/livro
Oxidative stress in neurology and in neurodegenerative processes (2020)
Gupta, Gaurav; Pathak, Sacchidanand; Rawat, Sarita; Mishra, Anurag; Singh, Yogendra; Mehta, Meenu; Satija, Saurabh; Khurana, Navneet; Pinto, Terezinha de Jesus Andreoli ; Shukla, Shakti; Pabreja, Kavita; Chellappan, Dinesh Kumar
Source: Role of oxidative stress in pathophysiology of diseases. Unidade: FCF
Subjects: ESTRESSE OXIDATIVO, NEUROLOGIA, DOENÇAS NEURODEGENERATIVAS, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. Oxidative stress in neurology and in neurodegenerative processes. Role of oxidative stress in pathophysiology of diseases. Tradução . Singapore: Springer Nature, 2020. . Disponível em: https://doi.org/10.1007/978-981-15-1568-2. Acesso em: 06 nov. 2024.
APA
Gupta, G., Pathak, S., Rawat, S., Mishra, A., Singh, Y., Mehta, M., et al. (2020). Oxidative stress in neurology and in neurodegenerative processes. In Role of oxidative stress in pathophysiology of diseases. Singapore: Springer Nature. doi:10.1007/978-981-15-1568-2
NLM
Gupta G, Pathak S, Rawat S, Mishra A, Singh Y, Mehta M, Satija S, Khurana N, Pinto T de JA, Shukla S, Pabreja K, Chellappan DK. Oxidative stress in neurology and in neurodegenerative processes [Internet]. In: Role of oxidative stress in pathophysiology of diseases. Singapore: Springer Nature; 2020. [citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/978-981-15-1568-2
Vancouver
Gupta G, Pathak S, Rawat S, Mishra A, Singh Y, Mehta M, Satija S, Khurana N, Pinto T de JA, Shukla S, Pabreja K, Chellappan DK. Oxidative stress in neurology and in neurodegenerative processes [Internet]. In: Role of oxidative stress in pathophysiology of diseases. Singapore: Springer Nature; 2020. [citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/978-981-15-1568-2
Artigo de periodico
Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review (2020)
Prasher, Parteek ; Sharma, Mousmee; Aljabali, Alaa A. A; Gupta, Gaurav ; Negi, Poonam; Kapoor, Deepak N; Singh, Inderbir; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Silva, Mateus Webba da; Bakshi, Hamid A; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M ; Dua, Kamal
Source: Drug Development Research. Unidade: FCF
Subjects: FÁRMACOS, COMPOSTOS ORGÂNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review. Drug Development Research, v. 81, p. 837–858, 2020Tradução . . Disponível em: https://doi.org/10.1002/ddr.21704. Acesso em: 06 nov. 2024.
APA
Prasher, P., Sharma, M., Aljabali, A. A. A., Gupta, G., Negi, P., Kapoor, D. N., et al. (2020). Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review. Drug Development Research, 81, 837–858. doi:10.1002/ddr.21704
NLM
Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, Pinto T de JA, Silva MW da, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review [Internet]. Drug Development Research. 2020 ; 81 837–858.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/ddr.21704
Vancouver
Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, Pinto T de JA, Silva MW da, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review [Internet]. Drug Development Research. 2020 ; 81 837–858.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/ddr.21704
Artigo de periodico
Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma (2018)
Gupta, Gaurav; Singhvi, Gautam; Chellappan, Dinesh Kumar; Sharma, Sanjay; Mishra, Anurag; Dahiya, Rajvir; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal
Source: Panminerva Medica. Unidade: FCF
Subjects: TRANSDUÇÃO DE SINAL CELULAR, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma. Panminerva Medica, v. 60, n. 3, p. 109-116, 2018Tradução . . Disponível em: https://doi.org/10.23736/S0031-0808.18.03462-6. Acesso em: 06 nov. 2024.
APA
Gupta, G., Singhvi, G., Chellappan, D. K., Sharma, S., Mishra, A., Dahiya, R., et al. (2018). Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma. Panminerva Medica, 60( 3), 109-116. doi:10.23736/S0031-0808.18.03462-6
NLM
Gupta G, Singhvi G, Chellappan DK, Sharma S, Mishra A, Dahiya R, Pinto T de JA, Dua K. Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma [Internet]. Panminerva Medica. 2018 ; 60( 3): 109-116.[citado 2024 nov. 06 ] Available from: https://doi.org/10.23736/S0031-0808.18.03462-6
Vancouver
Gupta G, Singhvi G, Chellappan DK, Sharma S, Mishra A, Dahiya R, Pinto T de JA, Dua K. Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma [Internet]. Panminerva Medica. 2018 ; 60( 3): 109-116.[citado 2024 nov. 06 ] Available from: https://doi.org/10.23736/S0031-0808.18.03462-6
Artigo de periodico
Tumor suppressor role of miR-503 (2018)
Gupta, Gaurav; Chellappan, Dinesh Kumar; Pinto, Terezinha de Jesus Andreoli ; Hansbro, Philip M; Bebawy, Mary; Dua, Kamal
Source: Panminerva Medica. Unidade: FCF
Subjects: ONCOGENES, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. Tumor suppressor role of miR-503. Panminerva Medica, v. 60, n. 1, p. 17-24, 2018Tradução . . Disponível em: https://doi.org/10.23736/S0031-0808.17.03386-9. Acesso em: 06 nov. 2024.
APA
Gupta, G., Chellappan, D. K., Pinto, T. de J. A., Hansbro, P. M., Bebawy, M., & Dua, K. (2018). Tumor suppressor role of miR-503. Panminerva Medica, 60( 1), 17-24. doi:10.23736/S0031-0808.17.03386-9
NLM
Gupta G, Chellappan DK, Pinto T de JA, Hansbro PM, Bebawy M, Dua K. Tumor suppressor role of miR-503 [Internet]. Panminerva Medica. 2018 ; 60( 1): 17-24.[citado 2024 nov. 06 ] Available from: https://doi.org/10.23736/S0031-0808.17.03386-9
Vancouver
Gupta G, Chellappan DK, Pinto T de JA, Hansbro PM, Bebawy M, Dua K. Tumor suppressor role of miR-503 [Internet]. Panminerva Medica. 2018 ; 60( 1): 17-24.[citado 2024 nov. 06 ] Available from: https://doi.org/10.23736/S0031-0808.17.03386-9
Artigo de periodico
Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches (2018)
Dua, Kamal; Krishna, Rapalli Vamshi; Shukla, Shakti Dhar; Singhvi, Gautam; Shastri, Madhur D; Chellappan, Dinesh Kumar; Satija, Saurabh; Mehta, Meenu; Gulati, Monica; Pinto, Terezinha de Jesus Andreoli ; Gupta, Gaurav; Hansbro, Philip M
Source: Biomedicine and Pharmacotherapy. Unidade: FCF
Subjects: ESTRESSE OXIDATIVO, MYCOBACTERIUM TUBERCULOSIS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUA, Kamal et al. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches. Biomedicine and Pharmacotherapy, v. 107, p. 1218-1229, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2018.08.101. Acesso em: 06 nov. 2024.
APA
Dua, K., Krishna, R. V., Shukla, S. D., Singhvi, G., Shastri, M. D., Chellappan, D. K., et al. (2018). Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches. Biomedicine and Pharmacotherapy, 107, 1218-1229. doi:10.1016/j.biopha.2018.08.101
NLM
Dua K, Krishna RV, Shukla SD, Singhvi G, Shastri MD, Chellappan DK, Satija S, Mehta M, Gulati M, Pinto T de JA, Gupta G, Hansbro PM. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches [Internet]. Biomedicine and Pharmacotherapy. 2018 ; 107 1218-1229.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.biopha.2018.08.101
Vancouver
Dua K, Krishna RV, Shukla SD, Singhvi G, Shastri MD, Chellappan DK, Satija S, Mehta M, Gulati M, Pinto T de JA, Gupta G, Hansbro PM. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches [Internet]. Biomedicine and Pharmacotherapy. 2018 ; 107 1218-1229.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.biopha.2018.08.101
Artigo de periodico-carta/editorial
Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases [Carta] (2018)
Dua, Kamal; Pinto, Terezinha de Jesus Andreoli ; Chellappan, Dinesh Kumar; Gupta, Gaurav; Bebawy, Mary; Hansbro, Philip M
Source: Panminerva Medica. Unidade: FCF
Subjects: BIOFILMES, DOENÇAS RESPIRATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUA, Kamal et al. Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases [Carta]. Panminerva Medica. Turin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.23736/S0031-0808.18.03402-X. Acesso em: 06 nov. 2024. , 2018
APA
Dua, K., Pinto, T. de J. A., Chellappan, D. K., Gupta, G., Bebawy, M., & Hansbro, P. M. (2018). Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases [Carta]. Panminerva Medica. Turin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.23736/S0031-0808.18.03402-X
NLM
Dua K, Pinto T de JA, Chellappan DK, Gupta G, Bebawy M, Hansbro PM. Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases [Carta] [Internet]. Panminerva Medica. 2018 ; 60( 1): 35-36.[citado 2024 nov. 06 ] Available from: https://doi.org/10.23736/S0031-0808.18.03402-X
Vancouver
Dua K, Pinto T de JA, Chellappan DK, Gupta G, Bebawy M, Hansbro PM. Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases [Carta] [Internet]. Panminerva Medica. 2018 ; 60( 1): 35-36.[citado 2024 nov. 06 ] Available from: https://doi.org/10.23736/S0031-0808.18.03402-X
Artigo de periodico
Nephrotoxicity in rats exposed to paracetamol: the protective role of moralbosteroid, a steroidal glycoside (2017)
Gupta, Gaurav; Chellappan, Dinesh Kumar; Kikuchi, Irene Satiko ; Pinto, Terezinha de Jesus Andreoli ; Pabreja, Kavita; Agrawal, Mohit; Singh, Yogendra; Tiwari, Juhi; Dua, Kamal
Source: Journal of Environmental Pathology, Toxicology and Oncology. Unidade: FCF
Subjects: ESTRESSE OXIDATIVO, ANTIOXIDANTES, PARACETAMOL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. Nephrotoxicity in rats exposed to paracetamol: the protective role of moralbosteroid, a steroidal glycoside. Journal of Environmental Pathology, Toxicology and Oncology, v. 36, n. 2, p. 113-119, 2017Tradução . . Disponível em: https://doi.org/10.1615/JEnvironPatholToxicolOncol.2017019457. Acesso em: 06 nov. 2024.
APA
Gupta, G., Chellappan, D. K., Kikuchi, I. S., Pinto, T. de J. A., Pabreja, K., Agrawal, M., et al. (2017). Nephrotoxicity in rats exposed to paracetamol: the protective role of moralbosteroid, a steroidal glycoside. Journal of Environmental Pathology, Toxicology and Oncology, 36( 2), 113-119. doi:10.1615/JEnvironPatholToxicolOncol.2017019457
NLM
Gupta G, Chellappan DK, Kikuchi IS, Pinto T de JA, Pabreja K, Agrawal M, Singh Y, Tiwari J, Dua K. Nephrotoxicity in rats exposed to paracetamol: the protective role of moralbosteroid, a steroidal glycoside [Internet]. Journal of Environmental Pathology, Toxicology and Oncology. 2017 ; 36( 2): 113-119.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1615/JEnvironPatholToxicolOncol.2017019457
Vancouver
Gupta G, Chellappan DK, Kikuchi IS, Pinto T de JA, Pabreja K, Agrawal M, Singh Y, Tiwari J, Dua K. Nephrotoxicity in rats exposed to paracetamol: the protective role of moralbosteroid, a steroidal glycoside [Internet]. Journal of Environmental Pathology, Toxicology and Oncology. 2017 ; 36( 2): 113-119.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1615/JEnvironPatholToxicolOncol.2017019457
Trabalho de evento-resumo
Dissolution enhancement of celecoxib by complexation with glucosyl-β-cyclodextrin-choline dichloride coprecipitate (2016)
Dua, Kamal; Madan, Jyotsana R; Gupta, Gaurav; Chellappan, Dinesh Kumar; Kikuchi, Irene Satiko ; Pinto, Terezinha de Jesus Andreoli
Source: Abstracts. Conference titles: Annual International Convention of Association of Pharmacy Professionals. Unidade: FCF
Assunto: FARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUA, Kamal et al. Dissolution enhancement of celecoxib by complexation with glucosyl-β-cyclodextrin-choline dichloride coprecipitate. 2016, Anais.. Tiruchirappalli: Anna University, 2016. . Acesso em: 06 nov. 2024.
APA
Dua, K., Madan, J. R., Gupta, G., Chellappan, D. K., Kikuchi, I. S., & Pinto, T. de J. A. (2016). Dissolution enhancement of celecoxib by complexation with glucosyl-β-cyclodextrin-choline dichloride coprecipitate. In Abstracts. Tiruchirappalli: Anna University.
NLM
Dua K, Madan JR, Gupta G, Chellappan DK, Kikuchi IS, Pinto T de JA. Dissolution enhancement of celecoxib by complexation with glucosyl-β-cyclodextrin-choline dichloride coprecipitate. Abstracts. 2016 ;[citado 2024 nov. 06 ]
Vancouver
Dua K, Madan JR, Gupta G, Chellappan DK, Kikuchi IS, Pinto T de JA. Dissolution enhancement of celecoxib by complexation with glucosyl-β-cyclodextrin-choline dichloride coprecipitate. Abstracts. 2016 ;[citado 2024 nov. 06 ]

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration